Event JSON
{
"id": "24495e7140a5632341999a4678a91e97d193eb4b9649dc5769bfef4b0d63a1ea",
"pubkey": "ead44b57e154d4e2b97728d5a24f0bbefdfc05edc2688838e48b4f2c598fa03b",
"created_at": 1726133852,
"kind": 1,
"tags": [
[
"d",
"e4999c34-d3df-48b6-991b-a9601b82c763"
],
[
"subject",
"Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs"
],
[
"r",
"https://www.cnbc.com/2024/09/12/eli-lilly-to-boost-output-of-weight-loss-diabetes-alzheimers-drugs.html"
],
[
"snaid",
"1b345621-9e2d-4375-b61a-1c5fa3f67d86"
],
[
"published_at",
"1726133834"
],
[
"p",
"ead44b57e154d4e2b97728d5a24f0bbefdfc05edc2688838e48b4f2c598fa03b"
],
[
"imeta",
"url https://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1726092846\u0026w=1920\u0026h=1080",
"alt Article image"
],
[
"p",
"5f7bc57f61a88f5c2728ac4576686198b2d761785d46ca59bb9af4ac31f59f91"
]
],
"content": "Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs\nhttps://image.cnbcfm.com/api/v1/image/107388672-1710764847941-gettyimages-2092473213-dsc01895copy_8zcnfedn.jpeg?v=1726092846\u0026w=1920\u0026h=1080\n\nDemand for Eli Lilly's Zepbound and Mounjaro has outstripped supply over the last year, forcing the company to invest heavily to increase production.\n\nhttps://www.cnbc.com/2024/09/12/eli-lilly-to-boost-output-of-weight-loss-diabetes-alzheimers-drugs.html",
"sig": "e0dc1ea9c7744fe2cec50fe3647d74aaa8f17db5cf134337a8cfe9b4bd310a2065e1130977f429fcc52de063284efba4172c0fbb79fb5e8cf8ef44847ea66f6c"
}
